日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

SHP2 inhibition displays efficacy as a monotherapy and in combination with JAK2 inhibition in preclinical models of myeloproliferative neoplasms.

在骨髓增生性肿瘤的临床前模型中,SHP2 抑制剂作为单一疗法以及与 JAK2 抑制剂联合使用均显示出疗效

Pandey Garima, Mazzacurati Lucia, Rowsell Tegan M, Horvat Nathan P, Amin Narmin E, Zhang Guolin, Akuffo Afua A, Colin-Leitzinger Christelle M, Haura Eric B, Kuykendall Andrew T, Zhang Ling, Epling-Burnette Pearlie K, Reuther Gary W

Correction: Porphyrin overdrive rewires cancer cell metabolism

更正:卟啉过载重塑癌细胞代谢

Adapa, Swamy R; Hunter, Gregory A; Amin, Narmin E; Marinescu, Christopher; Borsky, Andrew; Sagatys, Elizabeth M; Sebti, Said M; Reuther, Gary W; Ferreira, Gloria C; Jiang, Rays Hy

JAK2 inhibitor persistence in MPN: uncovering a central role of ERK activation

JAK2抑制剂在MPN中的持续作用:揭示ERK激活的核心作用

Pandey, Garima; Kuykendall, Andrew T; Reuther, Gary W

HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms

HDAC11 缺陷会破坏骨髓增生性肿瘤中癌基因诱导的造血作用

Yue, Lanzhu; Sharma, Vasundhara; Horvat, Nathan P; Akuffo, Afua A; Beatty, Matthew S; Murdun, Cem; Colin, Christelle; Billington, Julia M R; Goodheart, William E; Sahakian, Eva; Zhang, Ling; Powers, John J; Amin, Narmin E; Lambert-Showers, Que T; Darville, Lancia N; Pinilla-Ibarz, Javier; Reuther, Gary W; Wright, Kenneth L; Conti, Chiara; Lee, Jennifer Y; Zheng, Xiaozhang; Ng, Pui Yee; Martin, Matthew W; Marshall, C Gary; Koomen, John M; Levine, Ross L; Verma, Amit; Grimes, H Leighton; Sotomayor, Eduardo M; Shao, Zonghong; Epling-Burnette, Pearlie K

Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms

骨髓增生性肿瘤的代谢脆弱性和表观遗传失调

Sharma, Vasundhara; Wright, Kenneth L; Epling-Burnette, Pearlie K; Reuther, Gary W

Finding a Jill for JAK: Assessing Past, Present, and Future JAK Inhibitor Combination Approaches in Myelofibrosis

寻找JAK抑制剂的良方:评估骨髓纤维化中JAK抑制剂联合治疗的过去、现在和未来策略

Kuykendall, Andrew T; Horvat, Nathan P; Pandey, Garima; Komrokji, Rami; Reuther, Gary W

Characterization of epidermal growth factor receptor (EGFR) P848L, an unusual EGFR variant present in lung cancer patients, in a murine Ba/F3 model

在小鼠 Ba/F3 模型中对表皮生长因子受体 (EGFR) P848L(一种存在于肺癌患者中的罕见 EGFR 变体)进行表征

Sarcar, Bhaswati; Gimbrone, Nicholas T; Wright, Gabriela; Remsing Rix, Lily L; Gordian, Edna R; Rix, Uwe; Chiappori, Alberto A; Reuther, Gary W; Santiago-Cardona, Pedro G; Muñoz-Antonia, Teresita; Cress, William Douglas

Preclinical characterization of INCB053914, a novel pan-PIM kinase inhibitor, alone and in combination with anticancer agents, in models of hematologic malignancies

在血液系统恶性肿瘤模型中,对新型泛PIM激酶抑制剂INCB053914进行临床前表征,包括单独使用以及与抗癌药物联合使用。

Koblish, Holly; Li, Yun-Long; Shin, Niu; Hall, Leslie; Wang, Qian; Wang, Kathy; Covington, Maryanne; Marando, Cindy; Bowman, Kevin; Boer, Jason; Burke, Krista; Wynn, Richard; Margulis, Alex; Reuther, Gary W; Lambert, Que T; Dostalik Roman, Valerie; Zhang, Ke; Feng, Hao; Xue, Chu-Biao; Diamond, Sharon; Hollis, Greg; Yeleswaram, Swamy; Yao, Wenqing; Huber, Reid; Vaddi, Kris; Scherle, Peggy

Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer Patients

西班牙裔肺癌患者的体细胞突变和祖源标记

Gimbrone, Nicholas T; Sarcar, Bhaswati; Gordian, Edna R; Rivera, Jason I; Lopez, Christian; Yoder, Sean J; Teer, Jamie K; Welsh, Eric A; Chiappori, Alberto A; Schabath, Matthew B; Reuther, Gary W; Dutil, Julie; Garcia, Miosotis; Ventosilla-Villanueva, Ronald; Vera-Valdivia, Luis; Yabar-Berrocal, Alejandro; Motta-Guerrero, Rodrigo; Santiago-Cardona, Pedro G; Muñoz-Antonia, Teresita; Cress, W Douglas

CRLF2 and JAK2 in B-progenitor acute lymphoblastic leukemia: a novel association in oncogenesis

B细胞前体急性淋巴细胞白血病中的CRLF2和JAK2:肿瘤发生中的一种新关联

Roll, J Devon; Reuther, Gary W